0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.69%
Revenue growth at 50-75% of 3606.HK's 15.92%. Martin Whitman would worry about competitiveness or product relevance.
27.08%
Gross profit growth above 1.5x 3606.HK's 13.91%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-3.63%
Negative EBIT growth while 3606.HK is at 12.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.39%
Negative operating income growth while 3606.HK is at 11.39%. Joel Greenblatt would press for urgent turnaround measures.
3008.70%
Net income growth above 1.5x 3606.HK's 9.75%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2827.27%
EPS growth above 1.5x 3606.HK's 11.11%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2827.27%
Diluted EPS growth above 1.5x 3606.HK's 11.11%. David Dodd would see if there's a robust moat protecting these shareholder gains.
3.02%
Share change of 3.02% while 3606.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.02%
Diluted share change of 3.02% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-52.42%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2536.42%
OCF growth of 2536.42% while 3606.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
1701.27%
FCF growth above 1.5x 3606.HK's 16.90%. David Dodd would verify if the firm’s strategic investments yield superior returns.
53271.44%
10Y revenue/share CAGR above 1.5x 3606.HK's 879.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
189.85%
5Y revenue/share CAGR 1.25-1.5x 3606.HK's 127.23%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-15.26%
Negative 3Y CAGR while 3606.HK stands at 86.16%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
5898.47%
OCF/share CAGR of 5898.47% while 3606.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
2081.08%
Positive OCF/share growth while 3606.HK is negative. John Neff might see a comparative advantage in operational cash viability.
604.15%
3Y OCF/share CAGR of 604.15% while 3606.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
300.18%
Net income/share CAGR at 50-75% of 3606.HK's 570.23%. Martin Whitman might question if the firm’s product or cost base lags behind.
-7.74%
Negative 5Y net income/share CAGR while 3606.HK is 52.72%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-35.85%
Negative 3Y CAGR while 3606.HK is 247.04%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
245.28%
3Y equity/share CAGR above 1.5x 3606.HK's 86.71%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-97.11%
Negative near-term dividend growth while 3606.HK invests at 21.32%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-100.00%
Firm’s AR is declining while 3606.HK shows 6.34%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.95%
We show growth while 3606.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
23.69%
Asset growth above 1.5x 3606.HK's 5.24%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.08%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-35.87%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while 3606.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
34.88%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.